Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Healthcare Medical Devices
Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.


TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd > 👀 The Mayo Clinic has purchased a VMS+3.2 model 📍🚀
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(12)
•••
Comment by jopatcloon Nov 20, 2024 7:00am
17 Views
Post# 36321155

RE:RE:👀 The Mayo Clinic has purchased a VMS+3.2 model 📍🚀

RE:RE:👀 The Mayo Clinic has purchased a VMS+3.2 model 📍🚀
jopatclo wrote: GranhamB the vulture see cood comment 

@silver88 Go time!
 
1
 
@yudi Very good new VMS+ has been acquired by: Duke University Hospital Mayo Clinic Phoenix Children’s Hospital Seattle Children’s Hospital
 
2
 
@cardinal Mayo paid 50,000 US dollars for their unit. They only allow specific usage of their name in news releases. They did a 100 tests with a dozen sonographers and loved it. Once they buy one it open doors for all their clinics and main centre to buy. Look for dozens to be sold to Mayo. I expect a few more right away. When Mayo buys, they all buy.
 
5
 
@cardinal Ascend loves VMS and I expect a deal very soon for large distribution through integration. Look for large centres in the south soon as well. Rochester full price sale is massive.
 
2
 
@nicolaosK #3 says Mayo bought it
 
1
 
@cardinal They paid $50,000 US. They will buy dozens. Mayo is in Rochester
@silver88 Go time!
 
1
 
@yudi Very good new VMS+ has been acquired by: Duke University Hospital Mayo Clinic Phoenix Children’s Hospital Seattle Children’s Hospital
 
2
 
@cardinal Mayo paid 50,000 US dollars for their unit. They only allow specific usage of their name in news releases. They did a 100 tests with a dozen sonographers and loved it. Once they buy one it open doors for all their clinics and main centre to buy. Look for dozens to be sold to Mayo. I expect a few more right away. When Mayo buys, they all buy.
 
5
 
@cardinal Ascend loves VMS and I expect a deal very soon for large distribution through integration. Look for large centres in the south soon as well. Rochester full price sale is massive.
 
2
 
@nicolaosK #3 says Mayo bought it
 
1
 
@cardinal They paid $50,000 US. They will buy dozens. Mayo is in Rochester


Interesting repost Us2.ai https://lnkd.in/ezuxgyqn #vpt,
Voir Us2.ai
Us2.ai a republi ceci
AI-based automated echo measurement improves exam efficiency/sonographer workflow and increases number of echoes performed per day. Dr. Kagiyama discusses results of AI-ECHO randomized crossover trial https://lnkd.in/ezuxgyqn

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities